Stay updated with breaking news from Pediatric Brain Tumor Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sarah ES Leary, MD, MS, details the significance of the FDA-approval of tovorafenib for patients with relapsed or refractory BRAF-positive pediatric low-grade glioma.
Sarah E. S. Leary, MD, MS, discusses the FDA approval of tovorafenib for pediatric patients with relapsed/refractory, BRAF-mutant low-grade glioma.
Michael Strahan and daughter Isabella shared on air Thursday that she was diagnosed with medulloblastoma in the fall.
Sarah E. S. Leary, MD, MS, spotlights the importance of developing effective treatments for pediatric patients with low-grade glioma, key findings with tovorafenib in patients with RAF mutations, and how this agent may influence the low-grade glioma therapeutic landscape going forward.
A Omaha mom who specializes in 3D imaging arranged to get a 3D rendering of the scans of her son's brain so her husband could see where the boy's tumor